A Brief Review on Breast cancer treatment and current challenges

  • Isha Shah Sigma Institute of Pharmacy, Vadodara,Gujarat, India.
  • Nensi Raytthatha Sigma Institute of Pharmacy, Vadodara,Gujarat, India.


Cancer is a global disease, so rational and effective treatment is needed. Breast cancer is one of the most common cancers in a woman and now the number of patients is increasing day by day. Therefore, development and research are underway for the effective treatment of breast cancer. Breast cancer treatment depends on the stage of cancer and the risk, based on this medical agents should be employed on patients to prevent breast cancer. In addition, breast cancer survival rates are rising which is good news for science but on the other hand the side effects of treatment present new challenges. An early-stage cancer diagnosis can save a patient's active or healthy life due to long-term and varied treatments that can be used for cancer otherwise breast cancer is a life-threatening disease. Breast cancer survivors not only have negative side effects of cancer treatment but also, have many other issues of previous treatment so it is a challenge for researchers. As a result, this review article deals with the effective treatment of breast cancer and its side effects. This review will help researchers better understand the long-term medical implications for breast cancer.

Keywords: Cancer, Breast cancer, Treatment


Download data is not yet available.


ACS. Global Cancer Facts & Figures 2nd Edition Atlanta: American Cancer Society. 2011.

Cobleigh MA, Vogel CL, Tripathy D, Robert NJ, Scholl S, Fehrenbacher L, et al. Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. J Clin Oncol. 1999;17(9):2639-48.

Patil S, Lalani R, Bhatt P, Vhora I, Patel V, Patel H, et al. Hydroxyethyl substituted linear polyethylenimine for safe and efficient delivery of siRNA therapeutics. RSC Advances. 2018;8(62):35461-73.

ACS. Breast Cancer. Atlanta: American Cancer Society. 2011.

Bhatt P, Vhora I, Patil S, Amrutiya J, Bhattacharya C, Misra A, et al. Role of antibodies in diagnosis and treatment of ovarian cancer: Basic approach and clinical status. Journal of Controlled Release. 2016;226:148-67.

Gabriel EM, Jatoi I. Breast cancer chemoprevention. Expert Rev Anticancer Ther. 2012;12(2):223-8.

Yewale C, Baradia D, Patil S, Bhatt P, Amrutiya J, Gandhi R, et al. Docetaxel loaded immunonanoparticles delivery in EGFR overexpressed breast carcinoma cells. Journal of Drug Delivery Science and Technology. 2018;45:334-45.

Forbes JF, Cuzick J, Buzdar A, Howell A, Tobias JS, Baum M. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial. Lancet Oncol. 2008;9(1):45-53.

Howell A, Cuzick J, Baum M, Buzdar A, Dowsett M, Forbes JF, et al. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet. 2005;365(9453):60-2.

Abe O, Abe R, Asaishi K, Enomoto K, Hattori T, Iino Y, et al. Effects of Radiotherapy and Surgery in Early Breast-Cancer-an Overview of the Randomized Trials. New England Journal of Medicine. 1995;333(22):1444-55.

Cuzick J. Radiotherapy for breast cancer. Journal of the National Cancer Institute. 2005;97(6):406-7.

Bhatt P, Patel D, Patel A, Patel A, Nagarsheth A. Oral Controlled Release Systems: Current Strategies and Challenges. In: Misra A, Shahiwala A, editors. Novel Drug Delivery Technologies: Innovative Strategies for Drug Re-positioning. Singapore: Springer Singapore; 2019. p. 73-120.

Bergh J, Jonsson PE, Glimelius B, Nygren P. A systematic overview of chemotherapy effects in breast cancer. Acta Oncol. 2001;40(2-3):253-81.

Beral V, Banks E, Reeves G, Bull D. Breast cancer and hormone-replacement therapy: the Million Women Study. The Lancet. 2003;362(9392):1330-1.

Craft BS, Hortobagyi GN, Moulder SL. Adjuvant biologic therapy for breast cancer. Cancer J. 2007;13(3):156-61.

Longo R, Torino F, Gasparini G. Targeted therapy of breast cancer. Curr Pharm Des. 2007;13(5):497-517.

Patel J, Amrutiya J, Bhatt P, Javia A, Jain M, Misra A. Targeted delivery of monoclonal antibody conjugated docetaxel loaded PLGA nanoparticles into EGFR overexpressed lung tumour cells. Journal of Microencapsulation. 2018;35(2):204-17.

Coleman RE, Marshall H, Cameron D, Dodwell D, Burkinshaw R, Keane M, et al. Breast-cancer adjuvant therapy with zoledronic acid. N Engl J Med. 2011;365(15):1396-405.

Franceschini G, Terribile D, Magno S, Fabbri C, Accetta C, Di Leone A, et al. Update on oncoplastic breast surgery. Eur Rev Med Pharmacol Sci. 2012;16(11):1530-40.

Rios J, Puhalla S. PARP inhibitors in breast cancer: BRCA and beyond. Oncology (Williston Park). 2011;25(11):1014-25.

Carrasco-Triguero M, Yi JH, Dere R, Qiu ZJ, Lei C, Li Y, et al. Immunogenicity assays for antibody-drug conjugates: case study with ado-trastuzumab emtansine. Bioanalysis. 2013;5(9):1007-23.

Patel P, Hanini A, Shah A, Patel D, Patel S, Bhatt P, et al. Surface Modification of Nanoparticles for Targeted Drug Delivery. In: Pathak YV, editor. Surface Modification of Nanoparticles for Targeted Drug Delivery. Cham: Springer International Publishing; 2019. p. 19-31.

Ciardiello F, Tortora G. Epidermal growth factor receptor (EGFR) as a target in cancer therapy: understanding the role of receptor expression and other molecular determinants that could influence the response to anti-EGFR drugs. Eur J Cancer. 2003;39(10):1348-54.

Yewale C, Baradia D, Vhora I, Patil S, Misra A. Epidermal growth factor receptor targeting in cancer: a review of trends and strategies. Biomaterials. 2013;34(34):8690-707.

Bhatt P, Lalani R, Mashru R, Misra A. Abstract 2065: Anti-FSHR antibody Fab’ fragment conjugated immunoliposomes loaded with cyclodextrin-paclitaxel complex for improved in vitro efficacy on ovarian cancer cells. Cancer Research. 2016;76(14 Supplement):2065.

Atkins JH, Gershell LJ. Selective anticancer drugs. Nat Rev Drug Discov. 2002;1(7):491-2.

Bhatt P, Lalani R, Vhora I, Patil S, Amrutiya J, Misra A, et al. Liposomes encapsulating native and cyclodextrin enclosed paclitaxel: Enhanced loading efficiency and its pharmacokinetic evaluation. International Journal of Pharmaceutics. 2018;536(1):95-107.
44 Views | 28 Downloads
How to Cite
Isha Shah, and Nensi Raytthatha. “A Brief Review on Breast Cancer Treatment and Current Challenges”. World Journal of Current Medical and Pharmaceutical Research, Apr. 2021, pp. 27-31, doi:10.37022/wjcmpr.vi.170.
Review Articles